Science Explorer Back to mapMap
Discussion

Sumitomo Dainippon Pharma (United States)

In research, Sumitomo Dainippon Pharma (United States) stands highest in Physical Sciences (#16,391 of 17,446 worldwide), over all time.

World rank, all time
#21,868
of 34,923
Rank in United States
#4,539
of 7,310
Research works
402
▲ 94% vs 2018-21
Citations
7.3k
18.2 per fractional work
Top-10% rate
8.6%
all institutions 10.0%
vs its own fields
0.82×
1.00× is exactly expected
Open access
66%
world 40%
International
45%
world 18%

What is Sumitomo Dainippon Pharma (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Physical SciencesDomain #16,391 of 17,446 5.8%189

Each strip is that field's whole ranked pool, with the notch where Sumitomo Dainippon Pharma (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Sumitomo Dainippon Pharma (United States) work in?

In 2022-now, 51% of research at Sumitomo Dainippon Pharma (United States) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (49%), Biochemistry, Genetics and Molecular Biology (16%), Neuroscience (6%). It does 2.0× the world's share of Life Sciences.

Health Sciences: 30 fractional works · 51.2% of its workMedicine: 29 fractional works · 48.8% of its workPsychiatry and Mental health: 4 fractional works · 7.4% of its workOncology: 3 fractional works · 4.5% of its workPulmonary and Respiratory Medicine: 3 fractional works · 4.4% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 3.7% of its workObstetrics and Gynecology: 2 fractional works · 2.6% of its workHematology: 2 fractional works · 2.6% of its workUrology: 1 fractional works · 2.3% of its workSurgery: 1 fractional works · 2.3% of its workGenetics: 1 fractional works · 2.2% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.0% of its workNeurology: 1 fractional works · 1.9% of its workEpidemiology: 1 fractional works · 1.9% of its workReproductive Medicine: 1 fractional works · 1.8% of its workPharmacology: 1 fractional works · 1.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.5% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.0% of its workRheumatology: 1 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.7% of its workFamily Practice: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.3% of its workAnatomy: 0 fractional works · 0.3% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.3% of its workGastroenterology: 0 fractional works · 0.3% of its workDermatology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workHealth Professions: 1 fractional works · 1.4% of its workEmergency Medical Services: 0 fractional works · 0.6% of its workGeneral Health Professions: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.6% of its workSmall Animals: 0 fractional works · 0.6% of its workDentistry: 0 fractional works · 0.3% of its workGeneral Dentistry: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.1% of its workLife Sciences: 19 fractional works · 32.0% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 16.4% of its workMolecular Biology: 7 fractional works · 11.6% of its workCancer Research: 1 fractional works · 1.8% of its workGenetics: 1 fractional works · 1.3% of its workMolecular Medicine: 0 fractional works · 0.8% of its workBiotechnology: 0 fractional works · 0.6% of its workCell Biology: 0 fractional works · 0.3% of its workNeuroscience: 4 fractional works · 6.4% of its workCellular and Molecular Neuroscience: 2 fractional works · 3.2% of its workBiological Psychiatry: 1 fractional works · 1.1% of its workCognitive Neuroscience: 1 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.5% of its workBehavioral Neuroscience: 0 fractional works · 0.4% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 4 fractional works · 6.0% of its workImmunology: 4 fractional works · 6.0% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 2.6% of its workPharmaceutical Science: 1 fractional works · 1.0% of its workPharmacology: 1 fractional works · 0.9% of its workToxicology: 0 fractional works · 0.7% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.4% of its workSocial Sciences: 6 fractional works · 10.7% of its workSocial Sciences: 2 fractional works · 3.4% of its workEducation: 1 fractional works · 1.4% of its workGender Studies: 1 fractional works · 1.1% of its workDemography: 0 fractional works · 0.9% of its workBusiness, Management and Accounting: 2 fractional works · 2.9% of its workStrategy and Management: 1 fractional works · 1.5% of its workAccounting: 1 fractional works · 1.1% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 2 fractional works · 2.9% of its workEconomics and Econometrics: 1 fractional works · 2.5% of its workFinance: 0 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.9% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.6% of its workSocial Psychology: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.3% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.3% of its workArts and Humanities: 0 fractional works · 0.3% of its workPhilosophy: 0 fractional works · 0.3% of its workPhysical Sciences: 4 fractional works · 6.2% of its workChemistry: 1 fractional works · 1.8% of its workSpectroscopy: 0 fractional works · 0.6% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workAnalytical Chemistry: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 1 fractional works · 1.5% of its workBiomedical Engineering: 0 fractional works · 0.5% of its workElectrical and Electronic Engineering: 0 fractional works · 0.5% of its workComputational Mechanics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 1 fractional works · 1.1% of its workStatistics and Probability: 1 fractional works · 1.1% of its workComputer Science: 0 fractional works · 0.6% of its workInformation Systems: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.5% of its workMaterials Science: 0 fractional works · 0.5% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workALL ITS WORKSumitomoDainippon Pharma…59fractional works, 2022-now
Life Sciences32%Physical Sciences6%Health Sciences51%Social Sciences11%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 23 fields, with their numbers
    1. Medicine2948.8%
    2. Health Professions11.4%
    3. Veterinary00.6%
    4. Dentistry00.3%
    5. Nursing00.1%
    1. Biochemistry, Genetics and Molecular Biology1016.4%
    2. Neuroscience46.4%
    3. Immunology and Microbiology46.0%
    4. Pharmacology, Toxicology and Pharmaceutics22.6%
    5. Agricultural and Biological Sciences00.4%
    1. Social Sciences23.4%
    2. Business, Management and Accounting22.9%
    3. Economics, Econometrics and Finance22.9%
    4. Psychology00.9%
    5. Decision Sciences00.3%
    6. Arts and Humanities00.3%
    1. Chemistry11.8%
    2. Engineering11.5%
    3. Mathematics11.1%
    4. Computer Science00.6%
    5. Environmental Science00.5%
    6. Materials Science00.5%
    7. Earth and Planetary Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.08× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 5.97× its world share, 4 worksImmunology and Micro…Neuroscience: 3.97× its world share, 4 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.45× its world share, 2 worksPharmacology, Toxico…Chemistry: 1.15× its world share, 1 worksChemistryComputer Science: 0.08× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.09× its world share, 0 worksEarth and Planetary …Engineering: 0.10× its world share, 1 worksEngineeringEnvironmental Science: 0.10× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.14× its world share, 0 worksMaterials ScienceMathematics: 0.93× its world share, 1 worksMathematicsDentistry: 0.59× its world share, 0 worksDentistryHealth Professions: 0.54× its world share, 1 worksHealth ProfessionsMedicine: 2.54× its world share, 28 worksMedicineNursing: 0.29× its world share, 0 worksNursingVeterinary: 4.19× its world share, 0 worksVeterinaryArts and Humanities: 0.10× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.90× its world share, 2 worksBusiness, Management…Decision Sciences: 0.35× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.35× its world share, 2 worksEconomics, Econometr…Psychology: 0.28× its world share, 0 worksPsychologySocial Sciences: 0.27× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.5×. Every wedge is a field page.

All 23 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics7.45×2 works
  2. Immunology and Microbiology5.97×4 works
  3. Veterinary4.19×0 works
  4. Neuroscience3.97×4 works
  5. Biochemistry, Genetics and Molecular Biology3.08×10 works
  6. Medicine2.54×28 works
  7. Economics, Econometrics and Finance1.35×2 works
  8. Chemistry1.15×1 works
  9. Mathematics0.93×1 works
  10. Business, Management and Accounting0.90×2 works
  11. Dentistry0.59×0 works
  12. Health Professions0.54×1 works
  13. Decision Sciences0.35×0 works
  14. Nursing0.29×0 works
  15. Psychology0.28×0 works
  16. Social Sciences0.27×2 works
  17. Materials Science0.14×0 works
  18. Engineering0.10×1 works
  19. Environmental Science0.10×0 works
  20. Arts and Humanities0.10×0 works
  21. Agricultural and Biological Sciences0.09×0 works
  22. Earth and Planetary Sciences0.09×0 works
  23. Computer Science0.08×0 works

Who are the top researchers at Sumitomo Dainippon Pharma (United States)?

Ranked on the quality score, Alex Avdeef, Jason M. Foulks and Oksana Tsinman lead among researchers whose main affiliation is Sumitomo Dainippon Pharma (United States).

  1. 1 Alex Avdeef United States · #396,749 worldwide 13k citations · 199 works
  2. 2 Jason M. Foulks United States · #1,155,022 worldwide 2.5k citations · 145 works
  3. 3 Oksana Tsinman United States · #1,283,270 worldwide 2k citations · 30 works
  4. 4 Konstantin Tsinman United States · #2,126,051 worldwide 891 citations · 26 works
  5. 5 Sadao Hirae United States · #4,060,976 worldwide 149 citations · 16 works
  6. 6 Antonio Castagna United States · #4,502,406 worldwide 451 citations · 68 works
  7. 7 Hajime Shirakawa United States · #4,513,687 worldwide 122 citations · 18 works
  8. 8 Gil D. Fine United States · #4,590,169 worldwide 207 citations · 22 works
All ranked researchers at Sumitomo Dainippon Pharma (United States)

What are the most cited papers from Sumitomo Dainippon Pharma (United States)?

The most cited paper from Sumitomo Dainippon Pharma (United States) is "Physicochemical Profiling (Solubility, Permeability and Charge State)" (Alex Avdeef, 2001), with 589 citations. Next come "Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia" (426) and "FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets" (394).

Most cited papers
#PaperReleasedCitations
1 Physicochemical Profiling (Solubility, Permeability and Charge State) Alex Avdeef · Current Topics in Medicinal Chemistry Sep 2001 589
2 Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia Taishiro Kishimoto, Masahiro Nitta, Michael R. Borenstein et al. · The Journal of Clinical Psychiatry 15 Oct 2013 426
3 FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets Naonobu Nishino et al. · Journal of Clinical Investigation Open access Jul 2008 394
4 Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Eric T. Baldwin, Irene T. Weber, Robert Charles et al. · Proceedings of the National Academy of Sciences Open access 15 Jan 1991 357
5 Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo Yoshiko Minakuchi · Nucleic Acids Research Open access 16 Jul 2004 337
All 60 most cited papers, with filters and sorting

Which keywords describe research at Sumitomo Dainippon Pharma (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Metabolic Syndrome, Cancer Therapy, Antipsychotic Drugs, Neurocognitive Deficits, Innate Immunity, Epidemiology, Urinary Incontinence and Neurological Disorders.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Metabolic Syndrome4▲ 8.7×6 topics
  2. Epidemiology4▲ 1.70×12 topics
  3. Inflammation3▲ 2.3×14 topics
  4. Cancer Therapy3▲ 8.1×7 topics
  5. Oxidative Stress3▲ 2.7×9 topics
  6. Antipsychotic Drugs2▲ 106×1 topic
  7. Neurocognitive Deficits2▲ 106×1 topic
  8. Cancer2▲ 2.8×9 topics
  9. Immunotherapy2▲ 4.8×7 topics
  10. Neurological Disorders2▲ 5.8×7 topics
  11. Depression2▲ 3.5×7 topics
  12. Financial Performance2▲ 5.6×3 topics
  13. Genetic Mutations2▲ 6.9×5 topics
  14. Innate Immunity2▲ 9.6×5 topics
  15. Chemotherapy2▲ 4.1×11 topics
  16. Corporate Governance2▲ 3.9×3 topics
  17. Prognostic Factors2▲ 6.5×5 topics
  18. Urinary Incontinence2▲ 37×2 topics
  19. Biomarkers2▲ 3.9×7 topics
  20. Clinical Trials2▲ 4.0×6 topics
  21. Cognitive Function2▲ 15×5 topics
  22. Hormone Therapy2▲ 33×3 topics
  23. Treatment Guidelines2▲ 13×3 topics
  24. Tumor Microenvironment2▲ 6.0×5 topics
  25. Genetic Variation2▲ 12×3 topics
  26. Benign Prostatic Hyperplasia1▲ 71×1 topic
  27. Lower Urinary Tract Symptoms1▲ 71×1 topic
  28. Neurobiology1▲ 9.3×4 topics
  29. Parkinson's Disease1▲ 9.8×7 topics
  30. Stress1▲ 6.6×3 topics
  31. Breast Cancer1▲ 8.6×5 topics
  32. Clinical Guidelines1▲ 7.7×3 topics
  33. Prostate Cancer1▲ 17×2 topics
  34. Surgical Treatment1▲ 12×2 topics
  35. Cell Signaling1▲ 13×5 topics
  36. Health-related Quality of Life1▲ 8.5×2 topics
  37. Monoclonal Antibodies1▲ 22×2 topics
  38. Signal Transduction1▲ 13×2 topics
  39. Hematopoietic Stem Cells1▲ 22×2 topics
  40. Uterine Fibroids1▲ 65×1 topic

Which research topics does Sumitomo Dainippon Pharma (United States) publish most on?

By volume in 2022-now: Schizophrenia research and treatment, Urinary Bladder and Prostate Research, Uterine Myomas and Treatments and Biosimilars and Bioanalytical Methods.

  1. 1 Schizophrenia research and treatment Psychiatry and Mental health 2 works
  2. 2 Urinary Bladder and Prostate Research Urology 1 works
  3. 3 Uterine Myomas and Treatments Obstetrics and Gynecology 1 works
  4. 4 Biosimilars and Bioanalytical Methods Immunology 1 works
  5. 5 Bipolar Disorder and Treatment Psychiatry and Mental health 1 works
  6. 6 Endometriosis Research and Treatment Reproductive Medicine 1 works
  7. 7 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  8. 8 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 1 works
  9. 9 Ubiquitin and proteasome pathways Molecular Biology 1 works
  10. 10 Acute Myeloid Leukemia Research Hematology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.7%not open34.3%

World: 40% of research is openly available.

with international co-authors44.9%domestic only55.1%

World: 18% is written across borders.

How has Sumitomo Dainippon Pharma (United States)'s research output changed?

Output in 2022-2025 was 94% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Sumitomo Dainippon Pharma (United States) as a percentage of every work published that year, 0.00032% in 2024.

still counting0.0010%0.0020%Sumitomo Dainippon Pharma (United States)0.00014% in 202519801990200020102020

Fractional works of Sumitomo Dainippon Pharma (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Marlborough

All research institutions in Marlborough

Share Sumitomo Dainippon Pharma (United States)'s ranking

Sumitomo Dainippon Pharma (United States) on Science Explorer

A card with Sumitomo Dainippon Pharma (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Sumitomo Dainippon Pharma (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.